UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.93B |
| 2 |
Apple
AAPL
|
+$2.12B |
| 3 |
NVIDIA
NVDA
|
+$1.43B |
| 4 |
Amazon
AMZN
|
+$1.14B |
| 5 |
Meta Platforms (Facebook)
META
|
+$950M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$530M |
| 2 |
SLB Ltd
SLB
|
+$482M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$362M |
| 4 |
iShares Gold Trust
IAU
|
+$322M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.27% |
| 2 | Financials | 7.81% |
| 3 | Healthcare | 6.22% |
| 4 | Consumer Discretionary | 5.48% |
| 5 | Industrials | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5451
Enanta Pharmaceuticals
ENTA
$393M
| $355K | ﹤0.01% |
20,315
-915
| -4% | -$12.1K |
|
5452
ClearPoint Neuro
CLPT
$463M
| $354K | ﹤0.01% |
52,021
-1,510
| -3% | -$10.6K |
|
5453
Adtran
ADTN
$665M
| $353K | ﹤0.01% |
64,937
+64,907
| +216,357% | +$414K |
|
5454
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$608M
| $353K | ﹤0.01% |
+7,814
| New | +$338K |
|
5455
Viemed Healthcare
VMD
$353M
| $353K | ﹤0.01% |
37,443
-861
| -2% | -$7.38K |
|
5456
Heartbeam
BEAT
$32.7M
| $352K | ﹤0.01% |
161,615
-16,098
| -9% | -$30.4K |
|
|
AMPS
5457
DELISTED
Altus Power
AMPS
| $352K | ﹤0.01% |
73,683
+47,299
| +179% | +$281K |
|
5458
South Plains Financial
SPFI
$858M
| $352K | ﹤0.01% |
13,153
-1,630
| -11% | -$43.7K |
|
|
NCZ
5459
Virtus Convertible & Income Fund II
NCZ
$306M
| $351K | ﹤0.01% |
29,318
-2,350
| -7% | -$27.3K |
|
|
HEQ
5460
John Hancock Hedged Equity & Income Fund
HEQ
$140M
| $351K | ﹤0.01% |
33,422
-6,641
| -17% | -$67.7K |
|
5461
Northrim BanCorp
NRIM
$599M
| $350K | ﹤0.01% |
27,700
-1,860
| -6% | -$23.5K |
|
5462
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$42.1M
| $349K | ﹤0.01% |
9,371
+3,233
| +53% | +$121K |
|
5463
Arbutus Biopharma
ABUS
$908M
| $348K | ﹤0.01% |
134,823
-5,148
| -4% | -$13.3K |
|
5464
Neumora Therapeutics
NMRA
$317M
| $348K | ﹤0.01% |
25,281
+25,025
| +9,775% | +$405K |
|
5465
ORIX
IX
$44.1B
| $347K | ﹤0.01% |
15,745
+960
| +6% | +$19.5K |
|
|
CEV
5466
Eaton Vance California Municipal Income Trust
CEV
$74.9M
| $346K | ﹤0.01% |
32,642
+9,605
| +42% | +$101K |
|
5467
Methode Electronics
MEI
$602M
| $346K | ﹤0.01% |
28,399
-44,390
| -61% | -$838K |
|
5468
First Trust Dividend Strength ETF
FTDS
$39.8M
| $345K | ﹤0.01% |
6,854
-798
| -10% | -$37.4K |
|
5469
Sasol
SSL
$7.17B
| $345K | ﹤0.01% |
44,158
+30,034
| +213% | +$247K |
|
5470
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
$56.6M
| $343K | ﹤0.01% |
11,577
-243
| -2% | -$6.95K |
|
5471
iShares MSCI Brazil Small-Cap ETF
EWZS
$207M
| $343K | ﹤0.01% |
23,571
-810
| -3% | -$11.5K |
|
5472
Pangaea Logistics
PANL
$496M
| $343K | ﹤0.01% |
49,153
+4,079
| +9% | +$33.4K |
|
5473
El Pollo Loco
LOCO
$463M
| $342K | ﹤0.01% |
35,159
+34,667
| +7,046% | +$312K |
|
5474
PUT
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
| $342K | ﹤0.01% |
3,000
| – | – |
|
5475
Sagimet Biosciences
SGMT
$577M
| $342K | ﹤0.01% |
63,136
+43,148
| +216% | +$310K |
|
Similar funds
UBS Group's Q1 2024 Portfolio in Review
As of Q1 2024, UBS Group held 10,491 positions worth $402B, up 20% from $334B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS Group deployed $39.6B of net new capital in Q1 2024, opening 1,295 new positions and adding to 3,917 existing holdings. Its largest new stake was Flutter Entertainment: 1,718,419 shares worth $339M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares MSCI ACWI ETF, an estimated $530M trimmed.
- UBS Group's largest Q1 2024 buy was Flutter Entertainment: 1,718,419 shares worth $339M.
- UBS Group added most to Microsoft in Q1 2024, an estimated $2.93B increase.
- UBS Group's biggest Q1 2024 reduction was iShares MSCI ACWI ETF, cutting an estimated $530M.
- UBS Group fully exited SLB Ltd in Q1 2024, selling an estimated $482M.
- UBS Group's ten largest holdings make up 19% of its $402B portfolio in Q1 2024.
- UBS Group opened 1,295 new positions and closed 1,237 in Q1 2024.
- UBS Group's portfolio value rose 20% quarter-over-quarter to $402B.
Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.